Randomised Phase III trials with large patient groups

We conduct randomised Phase III trials with large populations and a broad spectrum of therapy areas.

Our model has been crafted to support our sponsors’ needs in the latter stages of drug development.

x

Examples of Richmond’s accelerated patient recruitment

Number one recruitment site out of 83 centres for a study involving patients with Transthyretin Amyloidosis with Cardiomyopathy. 64 patients were recruited within three months.

Richmond recruited 10% of the total patient volunteers needed for a global heart failure trial in just two months.

We are experts in conducting randomised Phase III clinical trials.

Our specialist clinical team has experience in conducting clinical trials with a broad spectrum of patient groups with common and rare diseases.

Get in touch today

Why choose Richmond Pharmacology for Phase III Clinical Trials

TAP OR CLICK A BLOCK BELOW TO LEARN MORE

Single centre studies

We are equipped to deliver single centre studies for early phase patient trials.

Read more +

Multi-disciplined teams

We have access to specialist consultants, professors and medical practitioners through our academic and medical partnerships.

Read more +

Hospital-style setting

Our multi-disciplinary team operate in a hospital-style setting which facilitates efficient, safe trial management.

Read more +

We maintain a 100% retention rate for patients in your study thanks to the engaged and responsive volunteer recruitment project managers.

Latest news

Richmond Pharmacology appoints Sandra Johnson as Director of Commercial Project Management

September 19, 2022
We are delighted to announce that Sandra Johnson will join Richmond Pharmacology as its new Director for Commercial Project Management
Read more

How telemonitoring can revolutionise the way we treat patients – Tom York

November 17, 2022
Richmond Pharmacology always searches for the most innovative processes to improve clinical trials and the patients’ experiences and treatments.
Read more

Events

JPW2022 (Japan Basic and Clinical Pharmacology Week 2022)

30 November – 3 December 2022
This event will be the 96th Annual Meeting of the Japanese Pharmacological Society and the 43rd Annual Meeting of the Japanese Society of Clinical Pharmacology. 
View event